Written by the Nuvirox Research Team
Key points
- Fewer than 800 clinicians nationwide are certified to provide CBT-I, and only 56% of those who are accept any insurance.
- Only about 3% of Medicare patients with insomnia receive CBT-I as their sole treatment, despite it being the guideline first-line recommendation.
- FDA-cleared digital CBT-I programs are starting to close the gap, with new CMS billing codes making some versions reimbursable.
Short answer: because there aren't enough trained providers, most of the ones who exist don't take insurance, and the system that's supposed to refer people to CBT-I mostly doesn't. Cognitive behavioral therapy for insomnia is the guideline-recommended first-line treatment for chronic insomnia, and yet fewer than 800 clinicians nationwide are certified to deliver it.
Why is CBT-I the recommended treatment if it's this hard to get?
CBT-I is a multi-component treatment addressing the behaviors and thought patterns that perpetuate insomnia — stimulus control, sleep restriction, cognitive restructuring, and sleep hygiene education — and it has a strong evidence base for outcomes and durability compared to sleep medication.
Guidelines from bodies including the American College of Physicians identify it as first-line specifically because the improvements tend to hold up after treatment ends, unlike medication, which mostly works while you're taking it.
So what's actually blocking access?
Researchers group the barriers into three buckets: a shortage of trained providers, primary care clinicians not screening for or referring to CBT-I in the first place, and patient-side factors like cost, awareness, and the time commitment of multiple sessions.
On the provider side specifically, only 56% of CBT-I providers who were surveyed accept any insurance coverage at all, and virtually none accept Medicare — one provider nationwide, per one analysis.
What human studies actually show
Cost-savings matched-control study, SleepioRx, 11,027 US patients (PMC12619666). This analysis of a fully automated, FDA-cleared digital CBT-I program found meaningful healthcare cost savings for patients who used it versus matched controls receiving standard care, alongside a stark access snapshot: initial in-person CBT-I visits average $260, subsequent sessions $227, and average provider wait times exceed 51 days.
Nationwide decentralized RCT of digital CBT-I in US adults (PMC12715469). This trial specifically recruited a sample with greater representation of lower socioeconomic status groups — the population most often locked out of in-person CBT-I by cost and geography — and tested a fully automated program against online sleep hygiene education, addressing the access gap directly rather than just describing it.
The honest counterweight: digital CBT-I has its own access problems. A round-table discussion among insomnia experts on telehealth-delivered CBT-I specifically raised concerns about under-representation of underserved and marginalized populations in the platforms' development and testing, and noted that digital therapies are frequently not covered by insurance either — meaning the digital shift narrows the access gap without eliminating it, and may reproduce some of the same disparities in different form.
What this article can and can't fix for you
This article can help you understand why CBT-I might feel impossible to access and what to ask for — it can't get you a referral. If you're dealing with chronic insomnia (trouble sleeping at least three nights a week for three months or more), the right next step is asking a primary care provider specifically about CBT-I or an FDA-cleared digital CBT-I program by name, since research shows many providers don't raise it unprompted. If your insomnia comes with symptoms of depression, anxiety, or another condition, that also deserves its own evaluation — CBT-I addresses insomnia specifically, not everything that can disrupt sleep.
Dosing and timeline
In-person CBT-I typically runs 4 to 8 weekly sessions. FDA-cleared digital CBT-I programs (delivered via app under a clinician's order) run a similar multi-week course through structured video and audio lessons, and newer CMS billing codes are making some versions reimbursable through traditional insurance and Medicare — worth specifically asking your provider about by name.
What does a CBT-I session actually involve, when you can get one?
A typical course covers several core components layered in over successive sessions: sleep restriction (temporarily limiting time in bed to build sleep pressure and consolidate sleep), stimulus control (re-associating the bed with sleep rather than wakeful frustration), cognitive restructuring (addressing anxious or catastrophic thoughts about sleep itself), and sleep hygiene education. It's structured and somewhat effortful — closer to physical therapy for sleep than a single relaxing conversation — which is part of why it works better than most people expect and also part of why engagement and completion rates matter so much in the research.
It's worth being specific with a primary care provider or therapist rather than just mentioning trouble sleeping: research on referral barriers found that clinicians often default to sleep hygiene advice or a prescription rather than a CBT-I referral, partly from unfamiliarity with what's available locally. Asking directly — 'can you refer me to CBT-I, or to an FDA-cleared digital CBT-I program' — tends to get a more specific answer than a general complaint about sleep.
The wait itself is also worth planning around rather than just enduring. Given that average provider wait times exceed 51 days in the cost-savings analysis cited above, it's reasonable to ask a provider about starting an FDA-cleared digital CBT-I program while an in-person referral is pending, rather than treating the two as sequential options. Several of the digital programs are designed to be ordered quickly by any licensed provider along the care continuum — not just specialists — which can meaningfully shorten the practical time-to-treatment compared to waiting for an in-person behavioral sleep medicine appointment alone.
Frequently asked questions
How do I find a CBT-I provider near me?
The Society of Behavioral Sleep Medicine maintains a provider directory; ask your primary care provider for a referral and specifically request CBT-I rather than general therapy.
Is digital CBT-I as effective as in-person?
Several RCTs, including large nationwide ones, have found FDA-cleared digital CBT-I programs produce meaningful improvements in insomnia symptoms; it's increasingly seen as a legitimate access-expanding option rather than a lesser substitute.
Will my insurance cover CBT-I?
It varies widely and is genuinely inconsistent — new CMS billing codes for FDA-cleared digital programs are improving reimbursability, but coverage isn't guaranteed. Ask specifically before starting.
What can I do while I wait for a CBT-I referral or slot?
Sleep hygiene fundamentals (consistent wake time, limiting screens before bed, avoiding late caffeine) and a supplement built around melatonin and calming botanicals can help in the interim, though neither replaces CBT-I for chronic insomnia.
FROM NUVIROX
Why we formulated Sleep+ Restore
Sleep+ Restore pairs 3 mg melatonin with magnesium glycinate, L-theanine, St. John's Wort, and 5-HTP — ingredients studied for their roles in sleep onset, relaxation, and mood-linked sleep disruption. It's backed by our 60-day money-back guarantee, long enough to actually evaluate it the way the research says you should.
Learn more about Sleep+ Restore →The bottom line
CBT-I is the treatment guidelines actually recommend first for chronic insomnia — and it's also the treatment most people functionally can't get, thanks to a provider shortage, poor insurance acceptance, and a referral system that often doesn't flag it. Digital CBT-I is narrowing that gap without closing it entirely. In the meantime, or alongside a CBT-I program once you get access to one, a supplement addressing sleep onset directly can help take the edge off while the longer-term behavioral work does the heavier lifting.
References
- Cost Savings Associated With Fully Automated Digital Cognitive Behavioral Therapy for Insomnia Disorder (SleepioRx): A Matched Control Study of US Patients. PMC12619666.
- The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial. PMC12715469.
- Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. PMID: 29619651
- See also: Racing Thoughts at Night
- See also: Meditation Apps for Sleep
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.